The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Protection From Retinopathy and Other Complications in Patients With Type 1 Diabetes of Extreme Duration
Open accessAbstract
OBJECTIVE: To assess complication prevalence and identify protective factors in patients with diabetes duration of ≥50 years. Characterization of a complication-free subgroup in this cohort would suggest that some individuals are protected from diabetes complications and allow identification of endogenous protective factors. RESEARCH DESIGN AND METHODS: Cross-sectional, observational study of 351 U.S. residents who have survived with type 1 diabetes for ≥50 years (Medalists). Retinopathy, nephropathy, neuropathy, and cardiovascular disease were assessed in relation to HbA1c, lipids, and advanced glycation end products (AGEs). Retrospective chart review provided longitudinal ophthalmic data for a subgroup. RESULTS: A high proportion of Medalists remain free from proliferative diabetic retinopathy (PDR) (42.6%), nephropathy (86.9%), neuropathy (39.4%), or cardiovascular disease (51.5%). Current and longitudinal (the past 15 years) glycemic control were unrelated to complications. Subjects with high plasma carboxyethyl-lysine and pentosidine were 7.2-fold more likely to have any complication. Of Medalists without PDR, 96% with no retinopathy progression over the first 17 years of follow-up did not experience retinopathy worsening thereafter. CONCLUSIONS: The Medalist population is likely enriched for protective factors against complications. These factors might prove useful to the general population with diabetes if they can be used to induce protection against long-term complications. Specific AGE combinations were strongly associated with complications, indicating a link between AGE formation or processing with development of diabetic vasculopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Global estimates of the prevalence of diabetes for 2010 and 2030
Shaw, J. E., Sicree, R. A., & Zimmet, P. Z. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.10.007 · Cited by 7,216
Stearne, M. R., Palmer, S. L., Hammersley, M. S., Franklin, S. L., Spivey, R. S., Lévy, J., Tidy, C. R., Bell, N. J., Steemson, J., Barrow, B. A., et al. (1998) · UCL Discovery (University College London) · Cited by 6,094
Klein, R. (1984) · Archives of Ophthalmology · doi:10.1001/archopht.1984.01040030398010 · Cited by 1,885
Feldman, E. L., Stevens, M. J., Thomas, P. K., Brown, M. B., Canal, N., & Greene, D. A. (1994) · Diabetes Care · doi:10.2337/diacare.17.11.1281 · Cited by 1,293
The Wisconsin Epidemiologic Study of Diabetic Retinopathy
Klein, R., Klein, B. E. K., Moss, S. E., Davis, M. D., & DeMets, D. L. (1987) · Ophthalmology · doi:10.1016/s0161-6420(87)33525-0 · Cited by 1,249
Chew, E. Y. (1996) · Archives of Ophthalmology · doi:10.1001/archopht.1996.01100140281004 · Cited by 713
Diabetes and advanced glycation endproducts
Vlassara, H., & Palace, M. R. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.00932.x · Cited by 697
Genuth, S., Sun, W., Cleary, P., Sell, D. R., Dahms, W., Malone, J., Sivitz, W., Monnier, V. M., & for the DCCT Skin Collagen Ancillary Study Group (2005) · Diabetes · doi:10.2337/diabetes.54.11.3103 · Cited by 427
Self-citationAdvanced glycation endproducts: what is their relevance to diabetic complications?
Ahmed, N., & Thornalley, P. J. (2007) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2006.00595.x · Cited by 371
Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes
STERN, D., YAN, S., YAN, S., & SCHMIDT, A. (2002) · Ageing Research Reviews · doi:10.1016/s0047-6374(01)00366-9 · Cited by 266
Chromatographic Quantitation of Plasma and Erythrocyte Pentosidine in Diabetic and Uremic Subjects
Odetti, P., Fogarty, J., Sell, D. R., & Monnier, V. M. (1992) · Diabetes · doi:10.2337/diab.41.2.153 · Cited by 255
Self-citationRetinopathy and Vision Loss in Insulin-dependent Diabetes in Europe
Sjølie, A. K., Stephenson, J., Aldington, S., Kohner, E., Janka, H., Stevens, L., Fuller, J., Karamanos, B., Tountas, C., Kofinis, A., et al. (1997) · Ophthalmology · doi:10.1016/s0161-6420(97)30327-3 · Cited by 216
Prevalence of diabetic retinopathy in an older community
Mitchell, P., Smith, W., Wang, J. J., & Attebo, K. (1998) · Ophthalmology · doi:10.1016/s0161-6420(98)93019-6 · Cited by 203
Keenan, H. A., Costacou, T., Sun, J. K., Doria, A., Cavellerano, J., Coney, J., Orchard, T. J., Aiello, L. P., & King, G. L. (2007) · Diabetes Care · doi:10.2337/dc06-2222 · Cited by 196
Self-citationDistribution of ApoA-I–Containing HDL Subpopulations in Patients With Coronary Heart Disease
Asztalos, B. F., Roheim, P. S., Milani, R. L., Lefevre, M., McNamara, J. R., Horvath, K. V., & Schaefer, E. J. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.12.2670 · Cited by 193
Self-citationSusceptibility to Diabetic Nephropathy Is Related to Dicarbonyl and Oxidative Stress
Beisswenger, P. J., Drummond, K. S., Nelson, R. G., Howell, S. K., Szwergold, B. S., & Mauer, M. (2005) · Diabetes · doi:10.2337/diabetes.54.11.3274 · Cited by 189
The pathological implications of protein glycation.
Brownlee, M. (1995) · PubMed · Cited by 153
The Association of Microalbuminuria with Diabetic Retinopathy
Cruickshanks, K. J., Ritter, L. L., Klein, R., & Moss, S. E. (1993) · Ophthalmology · doi:10.1016/s0161-6420(93)31562-9 · Cited by 147
Sell, D. R., Strauch, C., Shen, W., & Monnier, V. M. (2007) · Biochemical Journal · doi:10.1042/bj20061645 · Cited by 144
Self-citationFosmark, D. S., Torjesen, P. A., Kilhovd, B. K., Berg, T. J., Sandvik, L., Hanssen, K. F., Agardh, C., & Agardh, E. (2006) · Metabolism · doi:10.1016/j.metabol.2005.08.017 · Cited by 122
Characteristics of Type 1 diabetes of over 50 years duration (the Golden Years Cohort)
Bain, S. C., Gill, G. V., Dyer, P., Jones, A. F., Murphy, M., Jones, K. E., Smyth, C., & Barnett, A. H. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.01029.x · Cited by 117
Henricsson, M., Nilsson, A., Groop, L., Heijl, A., & Janzon, L. (1996) · Acta Ophthalmologica Scandinavica · doi:10.1111/j.1600-0420.1996.tb00727.x · Cited by 73
Amore, A., Cirina, P., Conti, G., Cerutti, F., Bagheri, N., Emancipator, S. N., & Coppo, R. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg428 · Cited by 46
Glucose control in the UKPDS: what did we learn?
Gale, E. A. M. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02503.x · Cited by 24
Cited by
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890
Diabetic retinopathy: current understanding, mechanisms, and treatment strategies
Duh, E. J., Sun, J. K., & Stitt, A. W. (2017) · JCI Insight · doi:10.1172/jci.insight.93751 · Cited by 1,057
Self-citationVascular Complications of Diabetes: Mechanisms of Injury and Protective Factors
Rask-Madsen, C., & King, G. L. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2012.11.012 · Cited by 846
Self-citationCurrent understanding of the molecular and cellular pathology of diabetic retinopathy
Antonetti, D. A., Silva, P. S., & Stitt, A. W. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-00451-4 · Cited by 645
Diabetic Macular Edema: Pathophysiology and Novel Therapeutic Targets
Das, A., McGuire, P. G., & Rangasamy, S. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2015.03.024 · Cited by 545
Metadata
- Authors
- Sun, J. K., Keenan, H. A., Cavallerano, J. D., Asztalos, B. F., Schaefer, E. J., Sell, D. R., Strauch, C. M., Monnier, V. M., Doria, A., Aiello, L. P., & King, G. L.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-03-21
- Volume
- 34
- Issue
- 4
- Pages
- 968-974
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2162869854
- Cited by
- 261
- References
- 26
- FWCI
- 9.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.